Study Reveals High Rates of Repeat Antibiotic Prescriptions for Respiratory Tract Infections in UK Primary Care

Study Reveals High Rates of Repeat Antibiotic Prescriptions for Respiratory Tract Infections in UK Primary Care

(IN BRIEF) A recent study conducted by researchers from the Universities of Bristol and Bath, King’s College London, and University Medical Center Utrecht highlights the concerning prevalence of repeat antibiotic prescriptions for respiratory tract infections (RTIs) within the same episode in primary care settings in England. Despite evidence suggesting little benefit from repeat prescriptions, nearly 20% of adults and 10% of children received a second course of antibiotics for lower RTIs, with almost half involving the same antibiotic class. Factors such as frequent GP visits for RTIs and prior repeat prescriptions were associated with higher rates of repeat antibiotic use. The authors emphasize the need for antimicrobial stewardship interventions to address this issue and mitigate the risks of antibiotic overuse and resistance, particularly among vulnerable age groups.

(PRESS RELEASE) BRISTOL, 8-Apr-2024 — /EuropaWire/ — A new study exploring the use of repeat antibiotic prescriptions for the same respiratory tract infection (RTI) episode – known as repeat ‘within-episode’ prescriptions – in primary care has found high rates of their use in England, despite evidence that they are of little benefit. The study authors, from the Universities of Bristol, Bath, King’s College London, and University Medical Center Utrecht, are calling for a reduction in their use and to make them a target for antimicrobial stewardship interventions.

RTIs are one of the most common reasons people visit a GP in the UK. Many RTIs are caused by viruses and current primary care guidelines recommend a no or delayed antibiotic prescribing strategy in the vast majority of patients. Despite this, 54 per cent of RTI consultations in UK primary care result in an antibiotic prescription, and RTIs account for 60 per cent of antibiotic prescribing in primary care worldwide. As such, RTIs are one of the key drivers of antimicrobial resistance.

The study, which analysed over 900,000 RTI episodes in clinical records from across 530 English general practices, found that nearly 20 per cent of adults and 10 per cent of children received a second course of antibiotics within the same episode of a lower RTI (chest infection). Almost half (48.3 per cent) of these repeat prescriptions involved the same antibiotic class.

Previous research has shown that for most child and adult patients with chest infections, particularly those without chronic lung disease, even a single antibiotic course is unlikely to have clinical benefit, raising concerns about antibiotic overuse and resistance.1 2

Factors associated with repeat prescriptions included frequent RTI-related GP visits and prior repeat within-episode RTI antibiotic prescriptions. Age was a significant determinant, with both young children (< 2 years) and older adults (65+) more likely to receive repeat prescriptions.

Arief Lalmohamed, Senior Lecturer at University Medical Center Utrecht and lead author of the study, said: “Repeat within-episode antibiotic use accounts for a significant proportion of all antibiotics prescribed for RTIs. In light of our findings, it’s clear that antimicrobial stewardship interventions must extend beyond initial antibiotic prescriptions to address within-episode repeats.”

Alastair Hay, a GP and Professor of Primary Care at the Centre for Academic Primary Care, University of Bristol, and Principal Investigator on the study, added: “It seems implausible that repeat antibiotic courses will have any benefit given that there is clear evidence that children and adults without chronic lung disease do not benefit from a first course of antibiotics, and that NICE recommends five-day antibiotic courses for the severest lower respiratory tract infections, such as pneumonia.”

Paper

‘Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study’ Arief Lalmohamed et al. in the Journal of Infection

Further information

1 Little P, Francis NA, Stuart B, O’Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, Rowley K, Euden J, Harman K, Coenen S, Read RC, Woods C, Butler CC, Faust SN, Leydon G, Wan M, Hood K, Whitehurst J, Richards-Hall S, Smith P, Thomas M, Moore M, Verheij T. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial. Lancet. 2021 Oct 16;398(10309):1417-1426. doi: 10.1016/S0140-6736(21)01431-8. Epub 2021 Sep 22. PMID: 34562391; PMCID: PMC8542731.

2 Little P, Stuart B, Moore M, Coenen S, Butler CC, Godycki-Cwirko M, Mierzecki A, Chlabicz S, Torres A, Almirall J, Davies M, Schaberg T, Mölstad S, Blasi F, De Sutter A, Kersnik J, Hupkova H, Touboul P, Hood K, Mullee M, O’Reilly G, Brugman C, Goossens H, Verheij T; GRACE consortium. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis. 2013 Feb;13(2):123-9. doi: 10.1016/S1473-3099(12)70300-6. Epub 2012 Dec 19. PMID: 23265995.

About the Centre for Academic Primary Care
The Centre for Academic Primary Care (CAPC) at the University of Bristol is a leading centre for primary care research in the UK, one of nine forming the NIHR School for Primary Care Research. It sits within Bristol Medical School, an internationally recognised centre of excellence for population health research and teaching.

Follow on X: @capcbristol and on LinkedIn.

Media Contact:

Tel: +44 (0)117 928 9000
Email: press-office@bristol.ac.uk

SOURCE: University of Bristol